Brief: Spago Q2 Loss Narrows To SEK 9.6 Mln
Aug 24 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST :
* SPAGO NANOMEDICAL INTERIM REPORT JANUARY-JUNE 2022
* Q2 NET SALES FOR QUARTER AMOUNTED TO KSEK 304 (KSEK 267)
* Q2 LOSS FOR QUARTER AMOUNTED TO KSEK -9,565 (KSEK -11,607)
* Q2 OPERATING EXPENSES FOR QUARTER AMOUNTED TO KSEK -11,084
(KSEK
-13,450)
Source text for Eikon: ID:nMFN15QtW7
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose